PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-0.1%
5Y CAGR+2.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-0.1%/yr
vs -10.9%/yr prior
5Y CAGR
+2.7%/yr
Consistent
Acceleration
+10.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.38M | -32.9% |
| 2024 | $6.52M | +1.0% |
| 2023 | $6.46M | +47.0% |
| 2022 | $4.39M | +21.2% |
| 2021 | $3.62M | -5.3% |
| 2020 | $3.83M | -6.7% |
| 2019 | $4.10M | -41.3% |
| 2018 | $6.98M | +57.2% |
| 2017 | $4.44M | -26.9% |
| 2016 | $6.07M | - |